News From the Wire

22:31:45 (UTC) 02-05-2026

Dutchie cannabis commerce platform launches 'Round Up the Change'

22:30:00 (UTC) 02-05-2026

Halcyon to deliver first commercial PCs equipped for ransomware resilience

22:28:31 (UTC) 02-05-2026

Cleo launches Autopilot, world's first AI financial assistant

22:25:44 (UTC) 02-05-2026

myRiva, Mesh aim to streamline travel booking and expense management

22:24:12 (UTC) 02-05-2026

The $194B shift: How quantum risk redefines value

22:22:04 (UTC) 02-05-2026

Clip unveils Clip Total 3 POS terminal for Mexican businesses

16:06:20 (UTC) 02-05-2026

PayPal appoints Enrique Lores as CEO, David W. Dorman as Independent Board Chair

16:04:00 (UTC) 02-05-2026

Payment gateway market size worth $114.30 billion by 2030 |CAGR: 21.8 percent



News from the Wire

Paysign to present at Oppenheimer 11th Annual Emerging Growth Conference

Thursday, January 22, 2026 — 20:15:08 (UTC)

Jan 21, 2026 4:30 PM Eastern Standard Time Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the Oppenheimer 11th Annual Emerging Growth Conference to be held February 3-4, 2026, through a virtual format.

The focus of the virtual conference is to feature one-on-one and small group meetings with emerging companies in technology, industrial growth and consumer sectors. Paysign’s Chief Financial Officer, Jeff Baker, will host one-on-one meetings on Tuesday, February 3.

Investors interested in registering may contact their Oppenheimer representative.

About Paysign

Paysign, Inc. (NASDAQ: PAYS) operates at the intersection of fintech and healthcare, integrating advanced payment processing and program management with tailored technologies for the plasma, pharmaceutical and life sciences industries. Their breakthrough patient affordability solutions ensure patients receive the financial assistance they need to adhere to prescribed therapies by mitigating the effects of copay accumulators and maximizers. Paysign specializes in blood and plasma donor compensation programs, as well as comprehensive engagement and management platforms optimized for life sciences. Paysign’s proprietary processing architecture supports physical, virtual, mobile and bank-based payments with real-time transaction intelligence, enabling efficient, compliant and scalable program delivery. Through advanced reporting, analytics and in-house 24/7 bilingual customer support, Paysign delivers measurable value, exceptional service and a superior experience for donors, patients, healthcare providers, pharmaceutical manufacturers and program sponsors across their growing fintech healthcare ecosystem. The company is committed to improving efficiencies, reducing costs, streamlining communications, increasing program performance and providing actionable insights to those they serve.

Notice to readers: These are archived articles. Contact information, links and other details may be out of date. We regret any inconvenience.

Source: Company press release.

Categories: Announcement

skyscraper ad